Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Data are from the National Prescription Audit of IMS Health.

Slides:



Advertisements
Similar presentations
Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
Advertisements

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012 Featured Article: Lydia W. Turner, David Nartey, Randall S. Stafford, Sonal Singh, and G.
European drug statistics What is the reason for the differences between the various EU countries Ulrich Schwabe Pharmakologisches Institut der Ruprecht-Karls-Universität.
1 The Budget Impact of Drugs Treating Rare Diseases in Canada: A MIDAS Sales Data Analysis April 14, 2015 Oral Presentation at the 2015 CADTH.
Exhibit 32.1 Five-Year Relative Survival Rates for Cancer in the United States and Canada, 1999 Copyright 2011 Health Administration Press.
Global Immunization Performance Update through 2011.
1 Canadian Institute for Health Information. National Health Expenditure Highlights 2.
Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, Copyright 2011 Health Administration.
In 2003, Medicaid spent $33.7 billion on drugs (19% of national spending for drugs and more than 10% of the Medicaid budget) Medicaid expenditures ($ billions)
CHOLESTAGEL Health Economics Study México March 7, 2008.
Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:
Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.
Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Amanda A. Honeycutt Linda.
Shalev V, et al. Arch Intern Med 2009; 169:
Canadian Study of Health and Aging The Prevalence of Dementia 1991 Baseline Study.
Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Estimates of People with Hepatitis C in Wyoming
Trial profile SAS denotes the Simvastatin in Aortic Stenosis Study
Estimates of People with Hepatitis C in Virginia
Combined Employee Premium Contribution and Deductible as a Share of Median Family Income Average employee share of premium plus average deductible as percent.
How Canada Compares Internationally
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Estimates of People with Hepatitis C in Mississippi
Estimates of People with Hepatitis C in Illinois
Estimates of People with Hepatitis C in Connecticut
National Trends in Per Capita Pharmaceutical Spending, 1980–2015
Estimates of People with Hepatitis C in Virginia
Share of median income (%)
Forecasting the Cost of Financing ART in Sub-Saharan Africa under Differential Funding Scenarios Tahvi Frank and Austin Carter July 25, 2018.
Estimates of People with Hepatitis C in Massachusetts
Estimates of People with Hepatitis C in Maine
Peltola H, Pääkkönen M. N Engl J Med 2014;370:
Global burden of hypertension in the adult population
Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62
Average annual out-of-pocket spending
Confirmed measles cases following the
$13.8 Billion Hip Fractures $8.68 billion (63.1%)
Estimates of People with Hepatitis C in Kansas
Risk of major congenital malformations among study infants according to fetal exposure to antihypertensives during first trimester alone* Variable ACE.
Estimates of People with Hepatitis C in Alabama
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
If everyone followed the Low-Risk Drinking Guidelines …
Sudhop T. et al. J Lipid Res 2009 Apr 20 [Epub ahead of print]
Potential mechanisms whereby statins may reduce the risk of stroke
Canada has two official languages: English and French
HOPE-3 Trial design: Patients without known cardiovascular disease, and with an intermediate risk of cardiovascular events, were randomized in a 2 x 2.
Emergency Departments(1)
Temporal changes in population rates of cardiac services, demographics, and AMI prevalence (relative to 1992) David A. Alter, et al, Circulation 2006;113;
Estimates of People with Hepatitis C in Nebraska
Baseline Characteristics of the Study Participants
Estimates of People with Hepatitis C in Arkansas
Average deductibles are also outpacing growth in median income.
Baseline Characteristics of the Subjects*
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]
Study Identification and Selection Process
Estimates of People with Hepatitis C in Wisconsin
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Characteristics of Participants in the Nurses Health Study According to Alcohol Intake Meir J.Stampfer et al N Engl J Med 2005;352:
Contemporary Clinical Opioid Use: Opportunities and Challenges
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Medication Adherence: WHO Cares?
Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.
Relative Risk of Onset of Cancer from the Cholesterol Treatment Trialists’ (CTT) Meta-Analysis of Statin Trials, According to Year of Onset Risk ratios.
IMPROVING HEALTH COVERAGE
How much is health spending expected to grow?
(A) Proportion of residents receiving prescriptions for antipsychotics, statins, benzodiazepines and trazodone each month, Ontario, Canada (October 2013.
Figure Prevalence for MS cumulated over 10 years in the United States per 100,000 population by age and sex 2010 Prevalence for MS cumulated over.
Presentation transcript:

Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. The scale for the number of prescriptions in Panel A is higher than that in Panel B by a factor of 10. Census estimates for 2001 are approximately 285 million for the United States and 30 million for Canada. Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

Standardized Annual Volume of Prescriptions for Ezetimibe, Statins, and All Lipid-Lowering Agents per 100,000 Persons, According to Country Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. Numbers have been standardized to the population on the basis of census data from the United States and Canada for 2001. Jackevicius CA, et al. NEJM 2008;358: [Epub Mar 30]

Annual Expenditures on Prescriptions for Lipid-Lowering Agents, According to Drug Class* Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

Standardized Annual Expenditures on Prescriptions for Ezetimibe, Statins, and All Lipid-Lowering Agents per 100,000 Persons, According to Country Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. Costs have been standardized to the population on the basis of census data from the United States and Canada for 2001. Costs have been adjusted for purchasing-power parity. Jackevicius CA, et al. NEJM 2008;358: [Epub Mar 30]